期刊文献+

Graves病的个体化治疗 被引量:15

下载PDF
导出
摘要 甲状腺功能亢进症(简称甲亢)是常见的内分泌疾病,2010年我国十城市甲状腺疾病流行病学调查结果显示甲亢患病率为1.1%,其中Graves病占所有甲亢病因中的85%。目前国内外均主要采用以下3种方法治疗甲亢:(1)抗甲状腺药物;(2)放射碘治疗;(3)手术。每种方法都有其优缺点。在临床工作中,往往面临的问题是针对某个甲亢患者应选择何种治疗方式更好,因此强调个体化治疗。本文主要介绍抗甲状腺药物治疗。
作者 高莹 郭晓蕙
出处 《临床内科杂志》 CAS 2011年第3期151-154,共4页 Journal of Clinical Internal Medicine
  • 相关文献

参考文献29

  • 1王曙.抗甲状腺药物治疗——Graves病治疗的首选[J].中国实用内科杂志,2010,30(1):95-96. 被引量:9
  • 2中华医学会内分泌学分会.《中国甲状腺疾病诊治指南》编写组中国甲状腺疾病诊治指南--甲状腺功能亢进症[J].中华内科杂志,:876-882.
  • 3Benker G, Reinwein D, Kahaly G,Tegler L,et al. Is there a methimazole dose effect on remission rate in Graves' disease? Results from a longterm prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs. Clin Endocrinol (Oxf). 1998,49:451-457.
  • 4He CT, Hsieh AT, Pei D, et al. Comparison of single daily dose of methimazole and propyhhiouracil in the treatment of Graves' hyperthyroidism. Clin Endocrinol(Oxf) ,2004,60:676-681.
  • 5FDA ALERT [06/04/2009 ] :Information for Heahhcare Professionals- Proovlthiouracil-Induced Liver Failure.
  • 6冯凭.Graves病的诊断与治疗[J].国外医学(内分泌学分册),2004,24(1):68-69. 被引量:27
  • 7Allannic H, Fauchet R, Orgiazzi J, ct al. Antithyroid drugs and Graves' disease : a prospective randomized evaluation of the efficacy of treatment duration. J Clin Endocrinol Metab, 1990,70:675-679.
  • 8Abraham P, Avcnell A, McGeoch SC, et al. Antithyroid drug regimen for treating Graves' hyperthyroidism. Cochrane Database Syst Rev, 2010 Jan20 ; ( 1 ) : CD003420. Review.
  • 9Vitti P, Rago T, Chiovato L, et al. Clinical features of patients with Graves' disease undergoing remission after antithyruid drug treatment. Thyroid, 1997,7:369-375.
  • 10Feldt-Rasmussen U, Schleusener H, Carayon P. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. J Clin Endocrinol Metab, 1994,78:98-102.

二级参考文献83

  • 1陈丹云,陈棠华.^(131)I与抗甲状腺药物治疗儿童Graves病的疗效对照研究[J].中华儿科杂志,2005,43(7):507-509. 被引量:14
  • 2Gregory AB. Graves' disease[J].N Engl J Med, 2008,358: 2594 - 2605.
  • 3Walter MA, Briel M, Christ-Crain M, et al. Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomized controlled trials[J]. BMJ,2007,334:514.
  • 4Vaidya B, Abraham P, Williams GR, et al. National storey of radioiodine use in benign thyroid disease [J].Clin Endocrinol, 2008,68:814 - 820.
  • 5Cooper DS. Anti-thyroid Drugs [ J ]. The New England Journal of Medicine ,2005,352:915 - 917.
  • 6MeLachlan SM,Rapoport B.Thyroid peroxidase as an autoantigen[J].Thyroid,2007,17(10):939-948.
  • 7Hofman LF,Foley TP,Henry J J,et al.The use of filter paper-dried blood spots for thyroid-antibody screening inadults[J].J Lab Clin Med,2004,144(6):307-312.
  • 8Sinclair D.Clinical and laboratory aspects of thyroid autoantibodies[J].Ann Clin Biochem,2006,43 Pt 3:173-183.
  • 9Baskin HJ,Cobin RH,Duick DS,et al.American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism[J].Endocr Pract,2002,8(6):457-469.
  • 10Quaratino S,Badami E,Pang YY,et al.Degenerate selfreactive human T-cell receptor causes spontaneous autoimmune disease in mice[J].Nat Meal,2004,10(9):920-926.

共引文献81

同被引文献161

引证文献15

二级引证文献140

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部